New Launch28 Nov 2024, 07:55 pm
Abbott Launches 14 Valent Pneumococcal Conjugate Vaccine (PCV-14) for Broader Protection in Children
AI Summary
Abbott, the global healthcare leader, has announced the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age. The PCV-14 valent vaccine offers broad protection, covering the highest number of serotypes, or strains, as compared to existing PCV-10 and PCV-13 vaccines. The vaccine protects against five more strains than the PCV 10, and two more strains than the PCV 13 vaccines currently used in India. The recommended immunization schedule for PneumoShield 14 is at 6, 10, and 14 weeks.
Key Highlights
- Abbott launches Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age.
- PCV-14 valent vaccine offers broad protection, covering the highest number of serotypes.
- PCV-14 protects against five more strains than the PCV 10, and two more strains than the PCV 13 vaccines.
- The recommended immunization schedule for PneumoShield 14 is at 6, 10, and 14 weeks.
- Pneumococcal vaccines are part of the government’s national immunization program to reduce childhood mortality in the country.